The Krannert Cardiovascular Research Center achieved many milestones between 2021-2024. Here are some of the highlights.
August 2021
Rohan Dharmakumar, PhD, becomes executive director of the Krannert Cardiovascular Research Center.
February 2022
Intramyocardial hemorrhage drives 2-fold expansion of MI size post revascularization.
July 2022
Suparna C. Clasen, MD, begins her role as director, clinical research operations to enhance and build the cardiovascular clinical research program.
October 2022
Study led by Rohan Dharmakumar, PhD, identifies that iron drives the formation of fatty tissue and leads to chronic heart failure in nearly half of heart attack survivors.
August 2022
Purdue University Weldon School of Biomedical Engineering PhD students begin doctoral training at the Krannert Cardiovascular Research Center in advanced cardiovascular imaging, instrumentation and therapeutics.
December 2022
First patient enrolls in clinical trial that aims to determine whether removing residual iron within damaged heart can lead to better outcomes.
January 2023
Ankit A. Desai, MD, contributes to the understanding that a SOX17 gene deficiency mediates pulmonary arterial hypertension, and Loren J. Field, PhD, helps identify a gene which facilitates cell cycle re-entry, the first step in regeneration, in infarcted hearts.
May 2023
World-renowned cardiovascular researchers arrive in Indianapolis for the inaugural Krannert Biennial, hosted by the Krannert Cardiovascular Research Center, to discuss the latest research and challenges in treating ischemic heart disease.
July 2023
The Krannert Cardiovascular Research Center exceeds its five year goal of receiving 10 R-Level National Institutes of Health grants within two years.
September 2023
The center expands its clinical research program with the recruitment of a new clinical research leader and additional research coordinators.
October 2023
With the center's input, the world's first clinical classification of heart attacks based on tissue damage is adopted by the Canadian Cardiovascular Society.
March 2024
Study led by Khadijah Breathett, MD, finds differences in donor heart acceptance by race and gender of patients on the transplant waiting list.